These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15746300)

  • 1. The metabolic syndrome: requiescat in pace.
    Reaven GM
    Clin Chem; 2005 Jun; 51(6):931-8. PubMed ID: 15746300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome.
    Cheal KL; Abbasi F; Lamendola C; McLaughlin T; Reaven GM; Ford ES
    Diabetes; 2004 May; 53(5):1195-200. PubMed ID: 15111486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome: is this diagnosis necessary?
    Reaven GM
    Am J Clin Nutr; 2006 Jun; 83(6):1237-47. PubMed ID: 16762930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correspondence between the adult treatment panel III criteria for metabolic syndrome and insulin resistance.
    Sierra-Johnson J; Johnson BD; Allison TG; Bailey KR; Schwartz GL; Turner ST
    Diabetes Care; 2006 Mar; 29(3):668-72. PubMed ID: 16505524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of plasma glucose and insulin concentrations in identifying patients with insulin resistance.
    Tuan CY; Abbasi F; Lamendola C; McLaughlin T; Reaven G
    Am J Cardiol; 2003 Sep; 92(5):606-10. PubMed ID: 12943888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia.
    Liao Y; Kwon S; Shaughnessy S; Wallace P; Hutto A; Jenkins AJ; Klein RL; Garvey WT
    Diabetes Care; 2004 Apr; 27(4):978-83. PubMed ID: 15047659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of diagnostic criteria for metabolic syndrome to identify insulin resistance].
    Butnoriene J; Norkus A; Bunevicius R; Lasas L
    Medicina (Kaunas); 2006; 42(6):455-63. PubMed ID: 16816539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the relationship between exercise and metabolic abnormalities? A review of the metabolic syndrome.
    Carroll S; Dudfield M
    Sports Med; 2004; 34(6):371-418. PubMed ID: 15157122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of metabolic markers to identify overweight individuals who are insulin resistant.
    McLaughlin T; Abbasi F; Cheal K; Chu J; Lamendola C; Reaven G
    Ann Intern Med; 2003 Nov; 139(10):802-9. PubMed ID: 14623617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin resistance syndrome: definition and dietary approaches to treatment.
    Reaven GM
    Annu Rev Nutr; 2005; 25():391-406. PubMed ID: 16011472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease.
    Yip J; Facchini FS; Reaven GM
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2773-6. PubMed ID: 9709945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome.
    ; Punthakee Z; Goldenberg R; Katz P
    Can J Diabetes; 2018 Apr; 42 Suppl 1():S10-S15. PubMed ID: 29650080
    [No Abstract]   [Full Text] [Related]  

  • 14. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Kahn R; Buse J; Ferrannini E; Stern M; ;
    Diabetes Care; 2005 Sep; 28(9):2289-304. PubMed ID: 16123508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
    Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome: one step forward, two steps back.
    Kim SH; Reaven GM
    Diab Vasc Dis Res; 2004 Oct; 1(2):68-75. PubMed ID: 16304726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals.
    Farin HM; Abbasi F; Reaven GM
    Am J Cardiol; 2006 Oct; 98(8):1053-6. PubMed ID: 17027570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals.
    Reaven G
    Diab Vasc Dis Res; 2005 Oct; 2(3):105-12. PubMed ID: 16334591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of insulin resistance and the metabolic syndrome with alternative definitions of impaired fasting glucose.
    Ford ES; Abbasi F; Reaven GM
    Atherosclerosis; 2005 Jul; 181(1):143-8. PubMed ID: 15939066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals.
    Reaven G
    Endocrinol Metab Clin North Am; 2004 Jun; 33(2):283-303. PubMed ID: 15158520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.